Conmed Corp
NYSE:CNMD

Watchlist Manager
Conmed Corp Logo
Conmed Corp
NYSE:CNMD
Watchlist
Price: 38.34 USD 2.24% Market Closed
Market Cap: $1.2B

EV/OCF

11.7
Current
35%
Cheaper
vs 3-y average of 18

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
11.7
=
Enterprise Value
$2.2B
/
Operating Cash Flow
$170.7m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
11.7
=
Enterprise Value
$2.2B
/
Operating Cash Flow
$170.7m

Valuation Scenarios

Conmed Corp is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (18), the stock would be worth $59 (54% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+255%
Average Upside
103%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 11.7 $38.34
0%
3-Year Average 18 $59
+54%
5-Year Average 41.5 $136.29
+255%
Industry Average 18.7 $61.3
+60%
Country Average 16.7 $54.75
+43%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
US
Conmed Corp
NYSE:CNMD
1.2B USD 11.7 25.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.2B USD 54.5 60
US
Abbott Laboratories
NYSE:ABT
158.3B USD 16.6 25.2
US
Stryker Corp
NYSE:SYK
125.3B USD 27 38.6
IE
Medtronic PLC
NYSE:MDT
106.9B USD 17.4 23.2
US
Boston Scientific Corp
NYSE:BSX
92B USD 22.3 25.8
DE
Siemens Healthineers AG
XETRA:SHL
40B EUR 15.6 18.9
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD 28.4 44.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.1B USD 38.5 42.6
US
Becton Dickinson and Co
NYSE:BDX
43.3B USD 17.5 24.7
US
Resmed Inc
NYSE:RMD
32B USD 16.2 21.6

Market Distribution

In line with most companies in the United States of America
Percentile
30th
Based on 9 518 companies
30th percentile
11.7
Low
0 — 11.7
Typical Range
11.7 — 23.6
High
23.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 11.7
Median 16.7
70th Percentile 23.6
Max 3 178 983.5

Conmed Corp
Glance View

Conmed Corporation, founded in the small city of Utica, New York, has carved a niche for itself in the competitive world of medical technology. The company, which began its journey in the mid-1970s, has evolved into a global player by specializing in a variety of surgical and patient care products. At its core, Conmed thrives on its deep expertise in the design and manufacturing of surgical instruments used predominantly in minimally invasive procedures. These include sophisticated medical devices for orthopedic, laparoscopic, robotic, and general surgeries. Conmed’s strategic focus has always been on innovation, driven by a commitment to enhance the surgeon's ability to provide superior patient care, which is evident in their continuous research and development efforts aimed at creating more efficient and effective tools for medical professionals. The revenue streams for Conmed are as diversified as their product offerings. By selling advanced surgical equipment and medical products to hospitals, surgical centers, and outpatient facilities worldwide, Conmed positions itself as a critical supplier in the healthcare industry. A significant portion of their income is derived from the repeat sales of disposable items and replacement parts required for these high-tech devices. This creates a continuous cycle of revenue through both initial capital sales and recurring sales of consumables, quintessential for sustaining robust financial stability. Furthermore, the company's growth strategy has been marked by strategic acquisitions, allowing it to broaden its array of products and enter new markets, thereby ensuring its continued prominence and adaptability in the ever-evolving landscape of healthcare technology.

CNMD Intrinsic Value
84.44 USD
Undervaluation 55%
Intrinsic Value
Price $38.34
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett